Beijing, China

Ying Chang

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Chang. Retrieved from https://idiyas.com/inventor/ying-chang-vml6yuzw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying Chang: Innovator in Pharmaceutical Compositions

Introduction

Ying Chang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work on pinocembrin.

Latest Patents

Ying Chang holds a patent for "Two types of crystalline of pinocembrin, their preparation and their use for manufacture of pharmaceutical compositions." This patent describes two crystalline forms of pinocembrin, designated as α and β, which differ in their bioavailability. These forms are utilized for treating and preventing cerebral ischemic diseases by providing protective action to the neurovascular unit and enhancing blood drug levels in vivo.

Career Highlights

Throughout his career, Ying Chang has worked with prominent organizations, including Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. and the Chinese Academy of Sciences. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Ying Chang has collaborated with notable colleagues such as Guanhua Du and Yang Lv, contributing to various projects in the pharmaceutical sector.

Conclusion

Ying Chang's innovative work in the field of pharmaceutical compositions highlights his importance as an inventor. His contributions, particularly in the development of pinocembrin, showcase the potential for advancements in treating cerebral ischemic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…